Efficacy and Safety of the Regulatory Polypeptides in Patients With Peripheral Atherosclerosis.

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.

Also called NCT05933720

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 120 participants (planned count) (from the registry)
Sponsor
Ryazan State Medical University (from the registry)
Registry
  • NCT NCT05933720
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Russia (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05933720. Non-randomized; no masking; primary purpose treatment. Start 2023-04-01 (actual); primary completion 2026-06-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy and Safety of the Regulatory Polypeptides in Patients With Peripheral Atherosclerosis.
Condition
Peripheral Arterial Occlusive Disease
Intervention (Drug)
Polypeptides
Intervention (Device)
Femoral-popliteal bypass grafting with a synthetic graft above the knee
Intervention (Other)
Routine conservative treatment
Lead sponsor
Ryazan State Medical University (class: other)

Record details

Record id
cardio:ct-nct05933720
Content hash
c41e7e82453fd6642fb10160f9ceb0af6a29d1ff3f5a8674057a27dcc27fc326